ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet


















FDA workshop: Insights on inhaled antifungals and antibacterials
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
NIAID workshop: What is a robust PK-PD package?
Modeling the value of an effective antibiotic — Megiddo et al.
The 6 meanings of “Lack of Access” (UNSLAP)
The hunt for oral antibiotics: Beyond Lipinski’s Rule of Five
FDA analysis of 40-years of antibacterial development: Dheman et al.
In Praise of Non-Inferiority
COVID-19 and the Long-Term Trajectory of AMR Efforts: Wellcome Trust Deep Dive
Plazomicin EU marketing application is withdrawn: Near zero market value of newly approved antibacterials
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Push! Pull! Push! Pull! / Highlights from Davos 2018
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet

The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet